Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) FCF Margin (2021 - 2025)

PAVmed (PAVM) has 5 years of FCF Margin data on record, last reported at 17980.0% in Q3 2025.

  • For Q3 2025, FCF Margin changed N/A year-over-year to 17980.0%; the TTM value through Sep 2025 reached 12510.34%, changed N/A, while the annual FY2024 figure was 1123.71%, 100835.0% up from the prior year.
  • FCF Margin reached 17980.0% in Q3 2025 per PAVM's latest filing, up from 19766.67% in the prior quarter.
  • Across five years, FCF Margin topped out at 230100.0% in Q1 2021 and bottomed at 25864.47% in Q3 2022.
  • Average FCF Margin over 5 years is 6840.5%, with a median of 6018.0% recorded in 2021.
  • Peak YoY movement for FCF Margin: crashed -23689206bps in 2022, then skyrocketed 2446030bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 6018.0% in 2021, then crashed by -154bps to 15286.61% in 2022, then surged by 92bps to 1149.38% in 2023, then soared by 138bps to 440.0% in 2024, then crashed by -4186bps to 17980.0% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 17980.0% in Q3 2025, 19766.67% in Q2 2025, and 19837.5% in Q1 2025.